Cargando…

The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials

OBJECTIVES: This meta-analysis aims to assess the clinical efficacy and safety of nemonoxacin in comparison with levofloxacin in treating community-acquired pneumonia (CAP). MATERIALS AND METHODS: The Pubmed, Embase, ClinicalTrials.gov., and the Cochrane databases were searched up to September 2018....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Shen-Peng, Lee, Hong-Zin, Lai, Chih-Cheng, Tang, Hung-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388749/ https://www.ncbi.nlm.nih.gov/pubmed/30863126 http://dx.doi.org/10.2147/IDR.S193233

Ejemplares similares

Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia
por: Zhao, Bo, et al.
Publicado: (2020)

Safety and Efficacy of Nemonoxacin vs Levofloxacin in Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Control Trials
por: Khan, Alina S, et al.
Publicado: (2023)

Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis
por: Zhao, Mingye, et al.
Publicado: (2022)

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
por: Tanaseanu, Cristina, et al.
Publicado: (2009)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
por: Chen, Yuancheng, et al.
Publicado: (2023)

Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
por: Endimiani, Andrea, et al.
Publicado: (2005)

The clinical efficacy of lefamulin in the treatment of elderly patients with community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020)

Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020)

Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
por: Ramirez, Julio A, et al.
Publicado: (2012)

Review of nemonoxacin with special focus on clinical development
por: Qin, Xiaohua, et al.
Publicado: (2014)

Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance
por: Yuan, Jinyi, et al.
Publicado: (2022)

Efficacy and Safety of Ceftaroline for the Treatment of Community-Acquired Pneumonia: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

Tigecycline Versus Levofloxacin in Hospitalized Patients With Community-Acquired Pneumonia: An Analysis of Risk Factors
por: Dartois, Nathalie, et al.
Publicado: (2013)

Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers
por: Zhang, Yi-fan, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae
por: Li, Xin, et al.
Publicado: (2021)

In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone
por: Roychoudhury, Siddhartha, et al.
Publicado: (2016)

Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study
por: Yadegarynia, Davood, et al.
Publicado: (2022)

Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: A meta-analysis
por: Jiang, Shan, et al.
Publicado: (2019)

Severe Hyponatremia due to Levofloxacin Treatment for Pseudomonas aeruginosa Community-Acquired Pneumonia in a Patient with Oropharyngeal Cancer
por: Mocan, Mihaela, et al.
Publicado: (2016)

COMPARATIVE EFFICACY AND SAFETY OF CEFIXIME AND CIPROFLOXACIN IN THE MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN IBADAN, NIGERIA
por: Ige, O.M., et al.
Publicado: (2015)

Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
por: Wu, Jheng-Yan, et al.
Publicado: (2023)

Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Ha, Seok Gyun, et al.
Publicado: (2018)

Correction to: Efficacy and safety of adjunctive corticosteroids in the treatment of severe community‑acquired pneumonia: a systematic review and meta‑analysis of randomized controlled trials
por: Wu, Jheng‑Yan, et al.
Publicado: (2023)

Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
por: Noreddin, Ayman M, et al.
Publicado: (2011)

The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

Comparison of levofloxacin (L) and cefotaxime (C) combined with ofloxacin (O) for treatment of severe community-acquired pneumonia (CAP) in the intensive care unit
por: Leroy, O, et al.
Publicado: (2004)

Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin
por: Kocsis, Bela, et al.
Publicado: (2016)

Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis
por: Lan, Shao-Huan, et al.
Publicado: (2020)

Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
por: Lode, H, et al.
Publicado: (2002)

Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis
por: Bi, Jirui, et al.
Publicado: (2016)

Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis
por: Huang, Jing, et al.
Publicado: (2019)

The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials
por: Chen, Chih-Wei, et al.
Publicado: (2019)

Pharmacotherapy and the risk for community-acquired pneumonia
por: Gau, Jen-Tzer, et al.
Publicado: (2010)

The Efficacy and Safety of Doripenem in the Treatment of Acute Bacterial Infections—A Systemic Review and Meta-Analysis of Randomized Controlled Trials
por: Lai, Chih-Cheng, et al.
Publicado: (2019)

Antimicrobial Resistance and Clinical Outcomes in Nursing Home-Acquired Pneumonia, Compared to Community-Acquired Pneumonia
por: Kang, Yun-Seong, et al.
Publicado: (2017)

Interim Study: Comparison Of Safety And Efficacy of Levofloxacin Plus Colistin Regimen With Levofloxacin Plus High Dose Ampicillin/Sulbactam Infusion In Treatment of Ventilator-Associated Pneumonia Due To Multi Drug Resistant Acinetobacter
por: Mosaed, Reza, et al.
Publicado: (2018)

Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia
por: Chang, Jer-Hwa, et al.
Publicado: (2016)

Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)
por: Kuzman, Ilija, et al.
Publicado: (2014)

Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Chen, Chia-Hung, et al.
Publicado: (2021)

In vitro Activities of Nemonoxacin and Other Antimicrobial Agents Against Human Mycoplasma and Ureaplasmas Isolates and Their Defined Resistance Mechanisms
por: Wang, Na, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ae9kvlfr1fsong2l0buqs524o8